Clinical Trial Update: Folate Supplementation in Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports results from using folate (folic acid) supplementation in individuals with schizophrenia; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• folic acid (folic acid)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2014-08-06